Galectin Therapeutics Inc (GALT)
3.34
-0.03
(-0.89%)
USD |
NASDAQ |
May 03, 16:00
3.36
+0.02
(+0.60%)
After-Hours: 20:00
Galectin Therapeutics Shareholders Equity (Quarterly): -60.24M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -60.24M |
September 30, 2023 | -50.87M |
June 30, 2023 | -51.13M |
March 31, 2023 | -42.65M |
December 31, 2022 | -32.19M |
September 30, 2022 | -22.34M |
June 30, 2022 | -15.22M |
March 31, 2022 | -6.193M |
December 31, 2021 | 2.616M |
September 30, 2021 | 9.249M |
June 30, 2021 | 17.12M |
March 31, 2021 | 18.23M |
December 31, 2020 | 24.19M |
September 30, 2020 | 31.54M |
June 30, 2020 | 37.01M |
March 31, 2020 | 42.75M |
December 31, 2019 | 45.60M |
September 30, 2019 | 49.48M |
June 30, 2019 | 51.62M |
March 31, 2019 | 6.842M |
December 31, 2018 | 6.898M |
September 30, 2018 | 8.97M |
June 30, 2018 | 9.775M |
March 31, 2018 | 2.648M |
December 31, 2017 | 1.193M |
Date | Value |
---|---|
September 30, 2017 | 2.67M |
June 30, 2017 | 5.817M |
March 31, 2017 | 9.635M |
December 31, 2016 | 12.02M |
September 30, 2016 | 12.03M |
June 30, 2016 | 14.61M |
March 31, 2016 | 19.54M |
December 31, 2015 | 25.05M |
September 30, 2015 | 19.79M |
June 30, 2015 | 24.77M |
March 31, 2015 | 28.68M |
December 31, 2014 | 27.97M |
September 30, 2014 | 29.94M |
June 30, 2014 | 32.45M |
March 31, 2014 | 34.96M |
December 31, 2013 | 8.227M |
September 30, 2013 | 8.173M |
June 30, 2013 | 3.727M |
March 31, 2013 | 5.723M |
December 31, 2012 | 7.917M |
September 30, 2012 | 3.057M |
June 30, 2012 | 4.906M |
March 31, 2012 | 6.824M |
December 31, 2011 | 4.397M |
September 30, 2011 | 0.823M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-60.24M
Minimum
Dec 2023
51.62M
Maximum
Jun 2019
2.557M
Average
9.249M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 405.33M |
Viking Therapeutics Inc | 933.89M |
89bio Inc | 536.31M |
Terns Pharmaceuticals Inc | 255.37M |
Enanta Pharmaceuticals Inc | 191.88M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 28.20M |
Total Liabilities (Quarterly) | 88.44M |